Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies

BACKGROUND: Prenatal screening for chromosome aneuploidies have constantly been evolving, especially with the introduction of cell-free fetal DNA (cfDNA) screening in the most recent years. This study compares the performance, costs and timing of test results of three cfDNA screening implementation...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tianhua, Gibbons, Clare, Rashid, Shamim, Priston, Megan K., Bedford, H. Melanie, Mak-Tam, Ellen, Meschino, Wendy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686697/
https://www.ncbi.nlm.nih.gov/pubmed/33228595
http://dx.doi.org/10.1186/s12884-020-03394-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686697/
https://www.ncbi.nlm.nih.gov/pubmed/33228595
http://dx.doi.org/10.1186/s12884-020-03394-w

Ejemplares similares